Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-09-14 to 2023-09-14
Current total value of award: $357.42
Description: 4562177867!ARTIFICIAL TEARS SOLU